Clinical trials
Phase 3 Lung Diseases, Obstructive trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2014 | 3 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 5 |
| Imperial College London | 1 |
| Novartis Pharmaceuticals | 1 |
| Royal Brompton & Harefield NHS Foundation Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases, Obstructive | 8 |
| Respiratory Tract Diseases | 7 |
| Bronchial Diseases | 6 |
| Lung Diseases | 6 |
| Asthma | 5 |
| Pulmonary Disease, Chronic Obstructive | 3 |
| Hypersensitivity | 2 |
| Immune System Diseases | 2 |
| Bronchitis, Chronic | 1 |
| Hypersensitivity, Immediate | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.